MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...

The drug targets for IBD will be discovered using the somatic genomics platform technology. Credit: NMK-Studio / Shutterstock.com. Merck & Co (MSD) has signed a multi-year research collaboration with ...

After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co. Looking to devise new drug targets ...

CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE)-- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year ...

Romanian Iulia Neagu, a PhD in physics at Harvard, sold the artificial intelligence startup Quotient to the American, Romanian-founded data giant Databricks. The two companies aim to improve the way ...

Databricks has acquired Quotient AI, a provider of AI agent evaluation and training software, to help enterprises scale AI agents in production more reliably. “Quotient AI was built to close the gap ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Quotient AI was founded in 2023 ...

Quotient Sciences, a CDMO that specializes in "niche and smaller volume" drugs that it says are often overlooked by bigger contract manufacturers, has extended a deal with Ipsen to produce Sohonos ...

Quotient Sciences now has expanded capabilities for handling HPAPI and products with OELs at or below 1µg/m³. Credit: Akimov Igor / Shutterstock.com. Quotient Sciences has extended its commercial ...

Abstract: In this paper, we present our GPU implementation of the quotient filter, a compact data structure designed to implement approximate membership queries. The quotient filter is similar to the ...